Comprehensive Financial Planning Inc. PA bought a new position in shares of Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 6,971 shares of the company’s stock, valued at approximately $557,000. Comprehensive Financial Planning Inc. PA owned approximately 1.27% of Virtus LifeSci Biotech Products ETF as of its most recent SEC filing.
Separately, Flow Traders U.S. LLC purchased a new position in Virtus LifeSci Biotech Products ETF during the second quarter worth about $431,000.
Virtus LifeSci Biotech Products ETF Stock Performance
Virtus LifeSci Biotech Products ETF stock opened at $84.71 on Friday. Virtus LifeSci Biotech Products ETF has a 52 week low of $57.61 and a 52 week high of $90.42. The business has a 50-day simple moving average of $85.43 and a 200 day simple moving average of $82.60.
Virtus LifeSci Biotech Products ETF Profile
The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.
Featured Stories
- Five stocks we like better than Virtus LifeSci Biotech Products ETF
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Want to see what other hedge funds are holding BBP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP – Free Report).
Receive News & Ratings for Virtus LifeSci Biotech Products ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virtus LifeSci Biotech Products ETF and related companies with MarketBeat.com's FREE daily email newsletter.
